Literature DB >> 776122

Dantrolene sodium: long-term effects in patients with muscle spasticity.

R L Joynt.   

Abstract

Seventy-seven patients with muscle spasticity secondary to central nervous system pathology were treated with dantrolene sodium for periods of up to two years. The drug was effective in reducing muscle spasms, clonus, muscle tone, and the force of muscle contraction elicited by Achilles tendon tap and tibial nerve stimulation, but improvement of function was seen less often. The incidence of side-effects was considerable, and poses a problem regarding patient acceptance of drug treatment.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 776122

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  3 in total

Review 1.  Dantrolene sodium: a review of its pharmacological properties and therapeutic efficacy in spasticity.

Authors:  R M Pinder; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1977-01       Impact factor: 9.546

2.  The effect of dantrolene sodium in relation to blood levels in spastic patients after prolonged administration.

Authors:  W J Meyler; H Bakker; J J Kok; S Agoston; H Wesseling
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-04       Impact factor: 10.154

Review 3.  Safety and efficacy of incobotulinumtoxinA as a potential treatment for poststroke spasticity.

Authors:  Andrea Santamato
Journal:  Neuropsychiatr Dis Treat       Date:  2016-01-27       Impact factor: 2.570

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.